Pfizer says Covid-19 pill Paxlovid cuts hospitalisation and deaths by 89%
Syringe and vial are seen in front of displayed new Pfizer logo in this illustration taken, on June 24, 2021.Reuters A trial of Pfizer’s experimental antiviral pill for Covid-19 was stopped early after the drug was shown to cut by 89 per cent the chances of hospitalisation or death for adults at risk of developing severe disease, the...